Cargando…

Nrf2 Activation With CDDO-Methyl Promotes Beneficial and Deleterious Clinical Effects in Transgenic Mice With Sickle Cell Anemia

Activation of Nrf2, a major transcription factor that drives the antioxidant defense system, is an emerging therapeutic strategy in Sickle Cell Disease (SCD). In this study, transgenic Sickle Cell Anemia mice (SS mice) treated with CDDO-Methyl (CDDO-Me), a potent Nrf2 activator, showed reduced progr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ihunnah, Chibueze A., Ghosh, Samit, Hahn, Scott, Straub, Adam C., Ofori-Acquah, Solomon F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127300/ https://www.ncbi.nlm.nih.gov/pubmed/35620281 http://dx.doi.org/10.3389/fphar.2022.880834

Ejemplares similares

Spatiotemporal Dysfunction of the Vascular Permeability Barrier in Transgenic Mice with Sickle Cell Disease
por: Ghosh, Samit, et al.
Publicado: (2012)

Comparative Analysis of Pain Behaviours in Humanized Mouse Models of Sickle Cell Anemia
por: Lei, Jianxun, et al.
Publicado: (2016)

Induction of Mitosis Delay and Apoptosis by CDDO-TFEA in Glioblastoma Multiforme
por: Tsai, Tai-Hsin, et al.
Publicado: (2021)

Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice
por: Gbotosho, Oluwabukola T., et al.
Publicado: (2020)

The SickleGenAfrica Network
por: Ofori-Acquah, Solomon F
Publicado: (2020)

Global Gene Expression Profiling of Endothelium Exposed to Heme Reveals an Organ-Specific Induction of Cytoprotective Enzymes in Sickle Cell Disease
por: Ghosh, Samit, et al.
Publicado: (2011)

Insulin-like Growth Factor-1 Prevents Hypoxia/Reoxygenation-Induced White Matter Injury in Sickle Cell Mice
por: Hazra, Rimi, et al.
Publicado: (2023)

Bardoxolone-Methyl (CDDO-Me) Impairs Tumor Growth and Induces Radiosensitization of Oral Squamous Cell Carcinoma Cells
por: Hermann, Cornelius, et al.
Publicado: (2021)

White-matter abnormalities and cognitive dysfunction are linked to astrocyte activation in sickle mice
por: Hazra, Rimi, et al.
Publicado: (2023)

The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity
por: Casares, Laura, et al.
Publicado: (2022)

Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids
por: Borella, Rebecca, et al.
Publicado: (2019)

Sickle Cell Disease: Genetics, Cellular and Molecular Mechanisms, and Therapies
por: Pace, Betty S., et al.
Publicado: (2012)

Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription
por: Yang, Lichuan, et al.
Publicado: (2009)

Sleep phenotype in the Townes mouse model of sickle cell disease
por: O’Donnell, Brett J., et al.
Publicado: (2018)

Effects of Individualized Treadmill Endurance Training on Oxidative Stress in Skeletal Muscles of Transgenic Sickle Mice
por: Gouraud, Etienne, et al.
Publicado: (2019)

The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia reperfusion injury in mice
por: Liu, Manchang, et al.
Publicado: (2013)

H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice
por: Vercellotti, Gregory M., et al.
Publicado: (2014)

The Triterpenoid CDDO-Methyl Ester Redirects Macrophage Polarization and Reduces Lung Tumor Burden in a Nrf2-Dependent Manner
por: Moerland, Jessica A., et al.
Publicado: (2023)

Essential role for ALCAM gene silencing in megakaryocytic differentiation of K562 cells
por: Tan, Fang, et al.
Publicado: (2010)

The Triterpenoid Nrf2 Activator, CDDO-Me, Decreases Neutrophil Senescence in a Murine Model of Joint Damage
por: Amirova, Kristiana M., et al.
Publicado: (2023)

Improvement of hemolytic anemia with GBT1118 is renoprotective in transgenic sickle mice
por: Ren, Guohui, et al.
Publicado: (2022)

Zanthoxylum Species: A Review of Traditional Uses, Phytochemistry and Pharmacology in Relation to Cancer, Infectious Diseases and Sickle Cell Anemia
por: Okagu, Innocent Uzochukwu, et al.
Publicado: (2021)

Dihydro-CDDO-Trifluoroethyl Amide (dh404), a Novel Nrf2 Activator, Suppresses Oxidative Stress in Cardiomyocytes
por: Ichikawa, Tomonaga, et al.
Publicado: (2009)

Sickle Cell Disease: New Opportunities and Challenges in Africa
por: Makani, J., et al.
Publicado: (2013)

Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response
por: Yahouédéhou, Sètondji Cocou Modeste Alexandre, et al.
Publicado: (2020)

Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy
por: Chan, John D, et al.
Publicado: (2018)

Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?
por: Hegemann, Lutz, et al.
Publicado: (2023)

Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development
por: Islam, Md. Aminul, et al.
Publicado: (2023)

Triterpenoid Dihydro-CDDO-Trifluoroethyl Amide Protects against Maladaptive Cardiac Remodeling and Dysfunction in Mice: A Critical Role of Nrf2
por: Xing, Yifan, et al.
Publicado: (2012)

Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana
por: Benneh-Akwasi Kuma, Amma, et al.
Publicado: (2018)

Deleterious effects of maternal ingestion of cocoa upon fetal ductus arteriosus in late pregnancy
por: Zielinsky, Paulo, et al.
Publicado: (2014)

Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis
por: Sales, Rahyssa Rodrigues, et al.
Publicado: (2022)

L-cysteine methyl ester overcomes the deleterious effects of morphine on ventilatory parameters and arterial blood-gas chemistry in unanesthetized rats
por: Getsy, Paulina M., et al.
Publicado: (2022)

A Point Mutation at C151 of Keap1 of Mice Abrogates NRF2 Signaling, Cytoprotection in Vitro, and Hepatoprotection in Vivo by Bardoxolone Methyl (CDDO-Me)
por: Gatbonton-Schwager, Tonibelle, et al.
Publicado: (2023)

CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages
por: Ball, Michael S., et al.
Publicado: (2016)

A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways
por: Zeng, Li, et al.
Publicado: (2018)

The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy
por: Xu, Dongwei, et al.
Publicado: (2017)

Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia
por: Belcher, John D., et al.
Publicado: (2018)

Long Tract of Untranslated CAG Repeats Is Deleterious in Transgenic Mice
por: Hsu, Ren-Jun, et al.
Publicado: (2011)

CDDO-Me: A Novel Synthetic Triterpenoid for the Treatment of Pancreatic Cancer
por: Deeb, Dorrah, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ahstki0pi15k4nu5te0o11k2hn